Kathryn H Schmitz1, Nancy I Williams2, Despina Kontos3, Mindy S Kurzer4, Mitchell Schnall3, Susan Domchek5, Jill Stopfer5, Mary Lou Galantino6, Wei-Ting Hwang7, Knashawn Morales7, Shandong Wu8, Laura DiGiovanni7, Domenick Salvatore7, Desire' Fenderson7, Jerene Good7, Kathleen Sturgeon7, Lorita Grant7, Cathy J Bryan7, Jess Adelman7. 1. Department of Biostatistics and Epidemiology, University of Pennsylvania, 8th floor Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104-6021, USA. Electronic address: Schmitz@mail.med.upenn.edu. 2. Department of Kinesiology, The Penn State University, 276 Recreation Building, University Park, PA 16802, USA. 3. Department of Radiology, University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104, USA. 4. Department of Food Science and Nutrition, 225 FScN, 1334 Eckles Ave, University of Minnesota, St. Paul, MN 55108, USA. 5. Department of Medicine, Division of Medical Oncology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. 6. Department of Physical Therapy, Richard Stockton College of New Jersey, 101 Vera King Farris Drive, Galloway, NJ 08205-9441, USA. 7. Department of Biostatistics and Epidemiology, University of Pennsylvania, 8th floor Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104-6021, USA. 8. Department of Radiology, University of Pittsburgh, 3352 5th Ave, Room 130, Pittsburgh, PA 15213, USA.
Abstract
PURPOSE: Women at elevated risk for breast cancer are motivated to reduce their risk. Current approaches rely primarily on hormonal intervention. A preventive exercise intervention might address the same hormonal issues, yet have fewer serious side effects and less negative impact on quality of life as compared to prophylactic mastectomy. WISER Sister was a randomized controlled trial which examined effects of two doses of exercise training on endogenous sex hormone exposure, hormonally active breast tissue, and other breast cancer risk factors. METHODS:Subjects for this single site trial were recruited from across the U.S., in collaboration with organizations that serve women at elevated risk, via emails, flyers, and letters. Eligibility criteria included age ≥ 18, eumenorrheic, and at elevated risk for breast cancer (e.g. BRCA1 or BRCA2 mutation and/or ≥ 18% lifetime risk according to prediction models). A 1:1:1 randomization scheme was used to allocate participants into: control, low dose (150 min/week), or high dose (300 min/week) home based treadmill exercise. Participants provided first morning urine samples daily for two menstrual cycles at study beginning and end for calculation of endogenous hormone exposure. In addition, women completed breast dynamic contrast enhanced magnetic resonance imaging, a fasting blood draw, a treadmill exercise test, and surveys at baseline and follow-up. DISCUSSION: WISER Sister randomized 139 women, 122 of whom completed the study. The overall drop-out rate was 12%. Findings will be useful in understanding the potential for exercise to assist with reducing risk for breast cancer among women at elevated risk.
RCT Entities:
PURPOSE:Women at elevated risk for breast cancer are motivated to reduce their risk. Current approaches rely primarily on hormonal intervention. A preventive exercise intervention might address the same hormonal issues, yet have fewer serious side effects and less negative impact on quality of life as compared to prophylactic mastectomy. WISER Sister was a randomized controlled trial which examined effects of two doses of exercise training on endogenous sex hormone exposure, hormonally active breast tissue, and other breast cancer risk factors. METHODS: Subjects for this single site trial were recruited from across the U.S., in collaboration with organizations that serve women at elevated risk, via emails, flyers, and letters. Eligibility criteria included age ≥ 18, eumenorrheic, and at elevated risk for breast cancer (e.g. BRCA1 or BRCA2 mutation and/or ≥ 18% lifetime risk according to prediction models). A 1:1:1 randomization scheme was used to allocate participants into: control, low dose (150 min/week), or high dose (300 min/week) home based treadmill exercise. Participants provided first morning urine samples daily for two menstrual cycles at study beginning and end for calculation of endogenous hormone exposure. In addition, women completed breast dynamic contrast enhanced magnetic resonance imaging, a fasting blood draw, a treadmill exercise test, and surveys at baseline and follow-up. DISCUSSION: WISER Sister randomized 139 women, 122 of whom completed the study. The overall drop-out rate was 12%. Findings will be useful in understanding the potential for exercise to assist with reducing risk for breast cancer among women at elevated risk.
Authors: Renate M Winkels; Kathleen M Sturgeon; Michael J Kallan; Lorraine T Dean; Zi Zhang; Margaret Evangelisti; Justin C Brown; David B Sarwer; Andrea B Troxel; Crystal Denlinger; Monica Laudermilk; Anna Fornash; Angela DeMichele; Lewis A Chodosh; Kathryn H Schmitz Journal: Contemp Clin Trials Date: 2017-07-21 Impact factor: 2.226
Authors: Kathryn H Schmitz; Nancy I Williams; Despina Kontos; Susan Domchek; Knashawn H Morales; Wei-Ting Hwang; Lorita L Grant; Laura DiGiovanni; Domenick Salvatore; Desire' Fenderson; Mitchell Schnall; Mary Lou Galantino; Jill Stopfer; Mindy S Kurzer; Shandong Wu; Jessica Adelman; Justin C Brown; Jerene Good Journal: Breast Cancer Res Treat Date: 2015-10-28 Impact factor: 4.872
Authors: Jeremy S Haley; Elizabeth A Hibler; Shouhao Zhou; Kathryn H Schmitz; Kathleen M Sturgeon Journal: Cancer Date: 2019-09-30 Impact factor: 6.860
Authors: Kathleen M Sturgeon; Lorraine T Dean; Mariane Heroux; Jessica Kane; Toni Bauer; Erica Palmer; Jin Long; Shannon Lynch; Linda Jacobs; David B Sarwer; Mary B Leonard; Kathryn Schmitz Journal: J Cancer Surviv Date: 2016-11-21 Impact factor: 4.442
Authors: Justin C Brown; Andrea B Troxel; Bonnie Ky; Nevena Damjanov; Babette S Zemel; Michael R Rickels; Andrew D Rhim; Anil K Rustgi; Kerry S Courneya; Kathryn H Schmitz Journal: Contemp Clin Trials Date: 2016-03-10 Impact factor: 2.226
Authors: Pedro Lopez; Daniel A Galvão; Dennis R Taaffe; Robert U Newton; Giovani Souza; Gabriel S Trajano; Ronei S Pinto Journal: Breast Cancer Date: 2020-08-19 Impact factor: 4.239
Authors: Rebecca R Turner; Liz Steed; Helen Quirk; Rosa U Greasley; John M Saxton; Stephanie Jc Taylor; Derek J Rosario; Mohamed A Thaha; Liam Bourke Journal: Cochrane Database Syst Rev Date: 2018-09-19